ArticleJACC. Case reports2025
Complication Management for Transcatheter Tricuspid Annuloplasty Dislocation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcatheter tricuspid valve replacement in arrhythmogenic right ventricular cardiomyopathy after prior cardioband annuloplasty: insights from the first-in-man case report.European heart journal. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe secondary tricuspid regurgitation (TR) is increasingly recognized as a major contributor to heart failure symptoms and mortality, particularly in elderly patients with complex comorbidities. Transcatheter tricuspid valve interventions have emerged as promising alternatives for these challenging cases. We report the cases of 2 patients with severe dyspnea and leg edema who were diagnosed with torrential TR. Both patients initially underwent transcatheter annuloplasty using the Cardioband system (Edwards Lifesciences), which led to significant improvements in TR severity and clinical symptoms. However, both experienced device dislocation and recurrent torrential TR within months. Subsequent complication management included orthotopic and heterotopic transcatheter tricuspid valve replacement, resulting in marked clinical improvement. This report underscores the potential and challenges of transcatheter therapies for severe functional TR, highlighting the importance of careful patient selection, close monitoring, and adaptive treatment strategies to optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.